CEL-SCI Corporation (CVM) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
CEL-SCI Corporation (CVM) Bundle
Looking to assess CEL-SCI Corporation's intrinsic value? Our CVM DCF Calculator integrates real-world data with extensive customization features, enabling you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .5 | .6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 20.73 | -100 | 0 | 0 | -19.82 | -19.82 | -19.82 | -19.82 | -19.82 |
EBITDA | -19.6 | -26.8 | -34.0 | -31.7 | -27.6 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | -4227.21 | -4801.69 | 100 | 100 | 100 | 20 | 20 | 20 | 20 | 20 |
Depreciation | .6 | 2.2 | .5 | 3.9 | 4.0 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 136.9 | 386.59 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -20.2 | -29.0 | -34.5 | -35.6 | -31.5 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | -4364.11 | -5188.28 | 100 | 100 | 100 | 20 | 20 | 20 | 20 | 20 |
Total Cash | 8.4 | 15.5 | 42.2 | 22.7 | 4.1 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 13.56 | 9.83 | 100 | 100 | 100 | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 |
Inventories | .8 | .8 | 2.0 | 2.0 | 2.2 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 169.07 | 146.79 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | 1.6 | 2.0 | 1.7 | 1.6 | 2.0 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 342.83 | 362.13 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.3 | -2.7 | -9.0 | -.7 | -.4 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | -72.57 | -482.38 | 100 | 100 | 100 | -34.51 | -34.51 | -34.51 | -34.51 | -34.51 |
Tax Rate, % | -0.53287 | -0.53287 | -0.53287 | -0.53287 | -0.53287 | -0.53287 | -0.53287 | -0.53287 | -0.53287 | -0.53287 |
EBITAT | -22.5 | -30.9 | -37.1 | -37.1 | -31.7 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -21.5 | -31.0 | -47.2 | -33.9 | -28.0 | .2 | .0 | .0 | .0 | .0 |
WACC, % | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 | 6.78 |
PV UFCF | ||||||||||
SUM PV UFCF | .2 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | 0 | |||||||||
Net Debt | 9 | |||||||||
Equity Value | -9 | |||||||||
Diluted Shares Outstanding, MM | 44 | |||||||||
Equity Value Per Share | -0.21 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: CEL-SCI Corporation’s financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model that adjusts to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for CEL-SCI Corporation (CVM).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to CEL-SCI Corporation (CVM).
- Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to suit CEL-SCI Corporation (CVM).
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to CEL-SCI Corporation (CVM).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of CEL-SCI Corporation (CVM).
How It Works
- Step 1: Download the Excel file.
- Step 2: Review CEL-SCI Corporation's (CVM) pre-filled financial data and forecasts.
- Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for CEL-SCI Corporation (CVM)?
- Accurate Data: Utilize real CEL-SCI financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you from starting from scratch.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Intuitive design and step-by-step guidance ensure accessibility for all users.
Who Should Use This Product?
- Healthcare Researchers: Explore innovative treatment methodologies and their market implications.
- Academics: Integrate advanced models into studies or lectures focused on immunotherapy.
- Investors: Evaluate your own investment strategies and assess potential outcomes for CEL-SCI Corporation (CVM).
- Market Analysts: Enhance your analysis with a customizable model tailored for biotech companies.
- Pharmaceutical Entrepreneurs: Understand how established firms like CEL-SCI Corporation (CVM) navigate the market landscape.
What the Template Contains
- Preloaded CVM Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.